These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 12797117

  • 21. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.
    Shiga N, Takeshima Y, Sakamoto H, Inoue K, Yokota Y, Yokoyama M, Matsuo M.
    J Clin Invest; 1997 Nov 01; 100(9):2204-10. PubMed ID: 9410897
    [Abstract] [Full Text] [Related]

  • 22. Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.
    Heemskerk H, de Winter CL, van Ommen GJ, van Deutekom JC, Aartsma-Rus A.
    Ann N Y Acad Sci; 2009 Sep 01; 1175():71-9. PubMed ID: 19796079
    [Abstract] [Full Text] [Related]

  • 23. Rescue of dystrophin mRNA of Duchenne muscular dystrophy by inducing exon skipping.
    Matsuo M, Takeshima Y.
    Acta Myol; 2005 Oct 01; 24(2):110-4. PubMed ID: 16550927
    [Abstract] [Full Text] [Related]

  • 24. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.
    Wilton SD, Lloyd F, Carville K, Fletcher S, Honeyman K, Agrawal S, Kole R.
    Neuromuscul Disord; 1999 Jul 01; 9(5):330-8. PubMed ID: 10407856
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL, Tuohy TM, Howard MT, Finkel RS, Medne L, Anderson CB, Weiss RB, Wilton SD, Flanigan KM.
    Ann Neurol; 2008 Jan 01; 63(1):81-9. PubMed ID: 18059005
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH, Sirsi SR, Latta DR, Lutz GJ.
    Mol Ther; 2006 Jul 01; 14(1):88-96. PubMed ID: 16488666
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
    Lu QL, Mann CJ, Lou F, Bou-Gharios G, Morris GE, Xue SA, Fletcher S, Partridge TA, Wilton SD.
    Nat Med; 2003 Aug 01; 9(8):1009-14. PubMed ID: 12847521
    [Abstract] [Full Text] [Related]

  • 35. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
    Takeshima Y, Nishio H, Sakamoto H, Nakamura H, Matsuo M.
    J Clin Invest; 1995 Feb 01; 95(2):515-20. PubMed ID: 7860733
    [Abstract] [Full Text] [Related]

  • 36. Design of 2'-O-Me RNA/ENA chimera oligonucleotides to induce exon skipping in dystrophin pre-mRNA.
    Takagi M, Yagi M, Ishibashi K, Takeshima Y, Surono A, Matsuo M, Koizumi M.
    Nucleic Acids Symp Ser (Oxf); 2004 Feb 01; (48):297-8. PubMed ID: 17150596
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping.
    Wein N, Avril A, Bartoli M, Beley C, Chaouch S, Laforêt P, Behin A, Butler-Browne G, Mouly V, Krahn M, Garcia L, Lévy N.
    Hum Mutat; 2010 Feb 01; 31(2):136-42. PubMed ID: 19953532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.